{
  "id": "mhgap#risk_safety_ac7d2b92",
  "content": "most efficacious medicine was risperidone. As research is needed to investigate side-effects of\nexpected, there were side-effects such as weight- medicines in this age group (201).\ngain, prolactin increase, higher fasting glucose, etc.\nImplementation considerations\ny Children and adolescents are a particularly\ny Adolescents living with bipolar disorder should\nvulnerable group. Given the very limited evidence\nbe involved in medicine choice in a supported\nand known side-effects of antipsychotics from\ndecision-making process.\nsystematic reviews in adults, antipsychotic\n95\nMental Health Gap Action Programme (mhGAP) guideline for mental, neurological and substance use disorders\nPSY7. In adults with bipolar disorder (current episode mania), are\nantipsychotic medicines and mood stabilizers effective and safe?\nRecommendation (update): 7.1 Oral antipsychotic medicines (namely aripiprazole, haloperidol,\nolanzapine, paliperidone or quetiapine) or mood stabilizers (namely\ncarbamazepine, lithium, valproic acid [sodium valproate]) should be offered\nto adults with bipolar disorder (current episode mania), carefully balancing\neffectiveness, side-effects and individual preference.\nStrength of recommendation: Strong\nCertainty of evidence: Low\n7.2 Valproic acid (sodium valproate) should not be used in women and\ngirls of childbearing potential owing to the high risk of birth defects and\nneurodevelopmental disorders in babies in utero.\nStrength of recommendation: Strong\nCertainty of evidence: Low",
  "metadata": {
    "source": "WHO mhGAP-IG 2023",
    "url": "https://www.who.int/",
    "condition": "General",
    "risk_band": "low",
    "topics": [
      "risk_safety",
      "referral",
      "psychoeducation"
    ],
    "is_clinical": true,
    "is_advice": false
  },
  "index_text": "General â€” Risk Safety most efficacious medicine was risperidone. As research is needed to investigate side-effects of\nexpected, there were side-effects such as weight- medicines in this age group (201).\ngain, prolactin increase, higher fasting glucose, etc.\nImplementation considerations\ny Children and adolescents are a particularly\ny Adolescents living with bipolar disorder should\nvulnerable group. Given the very limited evidence\nbe involved in medicine choice in a supported\nand known side-effects of antipsychotics from\ndecision-making process.\nsystematic reviews in adults, antipsychotic\n95\nMental Health Gap Action Programme (mhGAP) guideline for mental, neurological and substance use disorders\nPSY7. In adults with bipolar disorder (current episode mania), are\nantipsychotic medicines and mood stabilizers effective and safe?\nRecommendation (update): 7.1 Oral antipsychotic medicines (namely aripiprazole, haloperidol,\nolanzapine, paliperidone or quetiapine) or mood stabilizers (namely\ncarbamazepine, lithium, valproic acid [sodium valproate]) should be offered\nto adults with bipolar disorder (current episode mania), carefully balancing\neffectiveness, side-effects and individual preference.\nStrength of recommendation: Strong\nCertainty of evidence: Low\n7.2 Valproic acid (sodium valproate) should not be used in women and\ngirls of childbearing potential owing to the high risk of birth defects and\nneurodevelopmental disorders in babies in utero.\nStrength of recommendation: Strong\nCertainty of evidence: Low Most efficacious medicine was risperidone. as research is needed to investigate side-effects of\nexpected, there were side-effects such as weight- medicines in this age group (201)."
}